Table 2 Clinical features, including PET values, in T1a and T1b superficial esophageal squamous cell carcinoma.

From: 18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters are associated with histological outcomes in superficial esophageal squamous cell carcinoma

  

pT1a (n = 29)

pT1b (n = 24)

P values

Sex, n

Male/Female

19/10

17/7

0.772†

Age, median (range), years

 

68 (41–77)

70 (40–77)

0.604‡

Location, n

Upper/Middle/Lower

2/17/10

2/18/4

0.326†

Size, median (range), mm

 

28 (4–76)

32.5 (10–122)

0.446‡

Macroscopic type, n

0–I/0–IIa/0–IIb/0–IIc/0–III

1/2/6/18/2

1/4/4/14/1

0.876†

Type of IPCL, n*

B1/B2/B3

23/3/3

13/2/8

0.094†

AVA, n*

None/Small/Middle/Large

8/9/12/0

4/4/8/7

0.012†

SUV max, average, (SD)

1.33 (1.96)

3.49 (3.99)

0.020‡

MTV, average, (SD)

0.89 (1.12)

1.58 (2.84)

0.034‡

TLG, average, (SD)

1.71 (4.12)

6.85 (13.2)

0.027‡

  1. AVA Avascular area, IPCL Intrapapillary capillary loop, MTV Metabolic tumor volume, SD Standard deviation, SUV Standardized uptake value, SUV Standardized uptake value, TLG Total legion glycolysis.
  2. *One patient did not undergo magnifying endoscopic observation.
  3. † Fisher's exact test, ‡ Wilcoxon rank-sum test.